Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06829381 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Tailored One Anastomosis Gastric Bypass

Study acronym: OAGB-TL
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria revised
    • Study description revised
    v4
  2. Enrollment target: 200 to 500
    • Primary endpoint revised
    • Secondary endpoints: 3 to 4
    • Publications: 1 to 21
    v3
  3. Secondary endpoints revised (3)
    • Study description shortened, about 173 words
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
One Anastomosis Gastric Bypass (OAGB) is the most common metabolic and bariatric surgery (MBS) in Israel, recognized for its effectiveness in achieving sustainable weight loss and mitigating obesity-related diseases. The metabolic outcomes of OAGB are significantly influenced by the length of the biliopancreatic limb (BPL). The objective of this study is to determine whether tailoring the BPL length to the total small bowel length (TSBL) results in more effective weight loss compared to patients undergoing OAGB with a fixed BPL of 180 cm. Efficacy and safety of this approach will also be evaluated, ensuring it does not lead to long-term morbidity or negatively impact patients' quality of life.
Trial Details
NCT Number NCT06829381
Lead Sponsor Tel-Aviv Sourasky Medical Center
Conditions
(from sponsor)		 Metabolic and Bariatric Surgery
Related terms Obesity, Weight Loss
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov